1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Mania Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Mania Clinical Trials by Region
2.2.2 Average Enrollment of Mania Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Mania Treatment, 2019

3. Region wise Mania Clinical Trials
3.1 Asia Pacific Mania Clinical Trials by Country
3.2 Europe Mania Clinical Trials by Country
3.3 North America Mania Clinical Trials by Country
3.4 Middle East and Africa Mania Clinical Trials by Country
3.5 South and Central America Mania Clinical Trials by Country

4. Mania Clinical Trial Trends
4.1 Start Year wise Mania Clinical Trials
4.2 Phase wise Mania Clinical Trials
4.3 Trial Status wise Mania Clinical Trials
4.4 Trial Type wise Mania Clinical Trials

5. Mania Average Enrollment Trends
5.1 Average Enrollment in Mania Trials by Year
5.2 Average Enrollment in Mania Trials by Phase
5.3 Average Enrollment in Mania Trials by Status
5.4 Average Enrollment in Mania Trials by Type of Trial

6. Companies Participating in Mania Clinical Trials
6.1 Mania Trials by Sponsor Type
6.2 Mania Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Mania Trials- Phase 1
7.2 Mania Trials- Phase 2
7.3 Mania Trials- Phase 3
7.4 Mania Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Mania Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Mania Clinical Trials and Enrolment
Figure 5: Europe - Country wise Mania Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Mania Clinical Trials and Enrolment
Figure 7: North America - Country wise Mania Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Mania Clinical Trials and Enrolment
Figure 9: Mania Clinical Trials by Phase
Figure 10: Mania Clinical Trials by Trial Status
Figure 11: Mania Clinical Trials by Type
Figure 12: Mania Clinical Trials by Sponsor Type
Figure 13: Mania Clinical Trials by Leading Sponsors
Figure 14: Mania Average Enrollment by Phase
Figure 15: Mania Average Enrollment by Trial Status
Figure 16: Mania Average Enrollment by Type
Figure 17: Mania- Average Enrolment by Type of Sponsors
Figure 18: Mania- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Mania Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Mania Clinical Trials and Enrolment
Table 5: Europe - Country wise Mania Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Mania Clinical Trials and Enrolment
Table 7: North America - Country wise Mania Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Mania Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Mania Average Enrollment by Phase
Table 15: Mania Average Enrollment by Trial Status
Table 16: Mania Average Enrollment by Type
Table 17: Mania- Average Enrolment by Type of Sponsors
Table 18: Mania- Enrolment by Leading Sponsors

Companies mentioned
Abbott Laboratories, AstraZeneca Plc, Dr. Reddy's Laboratories Ltd, Eli Lilly and Co, Intas Pharmaceuticals Ltd, Johnson & Johnson, Novartis AG, Otsuka Holdings Co Ltd, Pfizer Inc, Teva Pharmaceutical Industries Ltd